These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin. Luo JL; Tan W; Ricono JM; Korchynskyi O; Zhang M; Gonias SL; Cheresh DA; Karin M Nature; 2007 Apr; 446(7136):690-4. PubMed ID: 17377533 [TBL] [Abstract][Full Text] [Related]
3. IKKα inibition by a glucosamine derivative enhances Maspin expression in osteosarcoma cell line. Leopizzi M; Cocchiola R; Milanetti E; Raimondo D; Politi L; Giordano C; Scandurra R; Scotto d'Abusco A Chem Biol Interact; 2017 Jan; 262():19-28. PubMed ID: 27931795 [TBL] [Abstract][Full Text] [Related]
4. Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease. Burton KA; Ashack KA; Khachemoune A Am J Clin Dermatol; 2016 Oct; 17(5):491-508. PubMed ID: 27358187 [TBL] [Abstract][Full Text] [Related]
5. Biomarker and Pathologic Predictors of Cutaneous Squamous Cell Carcinoma Aggressiveness. Khandelwal AR; Ma X; Egan P; Kaskas NM; Moore-Medlin T; Caldito G; Abreo F; Gu X; Aubrey L; Milligan E; Nathan CA Otolaryngol Head Neck Surg; 2016 Aug; 155(2):281-8. PubMed ID: 27095050 [TBL] [Abstract][Full Text] [Related]
6. Investigating proteome changes between primary and metastatic cutaneous squamous cell carcinoma using SWATH mass spectrometry. Azimi A; Lo K; Kim J; Fernandez-Penas P J Dermatol Sci; 2020 Aug; 99(2):119-127. PubMed ID: 32651104 [TBL] [Abstract][Full Text] [Related]
7. Maspin suppresses growth, proliferation and invasion in cutaneous squamous cell carcinoma cells. Zhu H; Mao Q; Liu W; Yang Z; Jian X; Qu L; He C Oncol Rep; 2017 May; 37(5):2875-2882. PubMed ID: 28405681 [TBL] [Abstract][Full Text] [Related]
8. Plexin-B1 and semaphorin 4D cooperate to promote cutaneous squamous cell carcinoma cell proliferation, migration and invasion. Cao J; Zhang C; Chen T; Tian R; Sun S; Yu X; Xiao C; Wang G; Liu Y; Fu M; Li W J Dermatol Sci; 2015 Aug; 79(2):127-36. PubMed ID: 26051877 [TBL] [Abstract][Full Text] [Related]
9. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline. Stratigos A; Garbe C; Lebbe C; Malvehy J; del Marmol V; Pehamberger H; Peris K; Becker JC; Zalaudek I; Saiag P; Middleton MR; Bastholt L; Testori A; Grob JJ; ; ; Eur J Cancer; 2015 Sep; 51(14):1989-2007. PubMed ID: 26219687 [TBL] [Abstract][Full Text] [Related]
11. Complement Component C3 and Complement Factor B Promote Growth of Cutaneous Squamous Cell Carcinoma. Riihilä P; Nissinen L; Farshchian M; Kallajoki M; Kivisaari A; Meri S; Grénman R; Peltonen S; Peltonen J; Pihlajaniemi T; Heljasvaara R; Kähäri VM Am J Pathol; 2017 May; 187(5):1186-1197. PubMed ID: 28322200 [TBL] [Abstract][Full Text] [Related]
12. Outcomes of Patients With Multiple Cutaneous Squamous Cell Carcinomas: A 10-Year Single-Institution Cohort Study. Levine DE; Karia PS; Schmults CD JAMA Dermatol; 2015 Nov; 151(11):1220-5. PubMed ID: 26177278 [TBL] [Abstract][Full Text] [Related]
13. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Brantsch KD; Meisner C; Schönfisch B; Trilling B; Wehner-Caroli J; Röcken M; Breuninger H Lancet Oncol; 2008 Aug; 9(8):713-20. PubMed ID: 18617440 [TBL] [Abstract][Full Text] [Related]
14. An emerging role for the nuclear localization of maspin in the suppression of tumor progression and metastasis. Goulet B; Chan G; Chambers AF; Lewis JD Biochem Cell Biol; 2012 Feb; 90(1):22-38. PubMed ID: 22047058 [TBL] [Abstract][Full Text] [Related]
15. Maspin expression in normal skin and usual cutaneous carcinomas. Reis-Filho JS; Torio B; Albergaria A; Schmitt FC Virchows Arch; 2002 Dec; 441(6):551-8. PubMed ID: 12461611 [TBL] [Abstract][Full Text] [Related]
17. High-risk cutaneous squamous cell carcinoma of the head and neck: results from 266 treated patients with metastatic lymph node disease. Veness MJ; Palme CE; Morgan GJ Cancer; 2006 Jun; 106(11):2389-96. PubMed ID: 16649220 [TBL] [Abstract][Full Text] [Related]
18. Expression of the tumour-suppressor maspin in temporal bone carcinoma. Marioni G; Zanoletti E; Stritoni P; Lionello M; Giacomelli L; Gianatti A; Cattaneo L; Blandamura S; Mazzoni A; Martini A Histopathology; 2013 Aug; 63(2):242-9. PubMed ID: 23730906 [TBL] [Abstract][Full Text] [Related]
19. Sentinel lymph node biopsy and risk factors for predicting metastasis in cutaneous squamous cell carcinoma. Krediet JT; Beyer M; Lenz K; Ulrich C; Lange-Asschenfeldt B; Stockfleth E; Terhorst D Br J Dermatol; 2015 Apr; 172(4):1029-36. PubMed ID: 25362868 [TBL] [Abstract][Full Text] [Related]
20. STMN1 overexpression correlates with biological behavior in human cutaneous squamous cell carcinoma. Li X; Wang L; Li T; You B; Shan Y; Shi S; Qian L; Cao X Pathol Res Pract; 2015 Nov; 211(11):816-23. PubMed ID: 26235036 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]